Targeting LAG-3 and PD-1 to Enhance T Cell Activation by Antigen-Presenting Cells-Reference-Cited by-同舟云学术

Targeting LAG-3 and PD-1 to Enhance T Cell Activation by Antigen-Presenting Cells

Published:2018-02-27 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Lichtenegger Felix S.,Rothe Maurine,Schnorfeil Frauke M.,Deiser Katrin,Krupka Christina,Augsberger Christian,Schlüter Miriam,Neitz Julia,Subklewe Marion

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference38 articles.

1. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010

2. Nivolumab in previously untreated melanoma without BRAF mutation;Robert;N Engl J Med,2015

3. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin’s lymphoma;Ansell;N Engl J Med,2015

4. Pembrolizumab versus chemotherapy for pd-l1-positive non-small-cell lung cancer;Reck;N Engl J Med,2016

5. An immunogenic personal neoantigen vaccine for patients with melanoma;Ott;Nature,2017

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking therapeutic potential: Targeting lymphocyte activation Gene-3 (LAG-3) with fibrinogen-like protein 1 (FGL1) in systemic lupus erythematosus;Journal of Translational Autoimmunity;2024-12

2. Targeting PD-1/PD-L1 in tumor immunotherapy: Mechanisms and interactions with host growth regulatory pathways;Cytokine & Growth Factor Reviews;2024-10

3. Advances in predictive biomarkers associated with immunotherapy in extensive-stage small cell lung cancer;Cell & Bioscience;2024-09-12

4. Immunotherapy for head and neck cancer: Fundamentals and therapeutic development;Auris Nasus Larynx;2024-08

5. PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets;EMBO Molecular Medicine;2024-07-19